In addition to their role in anogenital cancer, human papillomaviruses (HPVs) are also involved in the development of a range of cutaneous lesions. HPV types 5 and 8 are associated with the development of skin cancers in individuals with Epidermodysplasia verruciformis (EV). A broad spectrum of HPV types are also commonly found in non-melanoma skin cancers in immunocompromised individuals, such as organ transplant recipients. The skin cancers in EV and immunocompromised patients occur predominantly at body sites exposed to ultra violet (UV) radiation, pointing to a key role for UV in their development. Here we show that the E6 protein from a range of cutaneous HPV types eectively inhibits apoptosis in response to UV damage. This occurs in both p53 null and wild type cells and does not require p53 degradation. Oncogene (2000) 19, 592 ± 598.
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Keywords: HPV; UV; apoptosis; skin HPVs are small DNA tumour viruses which are closely associated with the development of speci®c human cancers (reviewed by zur zur Hausen, 1996) . A number of cellular targets of the viral oncogenes of anogenital viruses have been identi®ed. These include the Rb and p53 proteins which are targeted by the viral E7 and E6 genes respectively (Dyson et al., 1989; Werness et al., 1990) . The p53 tumour suppressor protein plays a pivotal role in cellular responses to stress factors such as DNA damage or hypoxia, principally through an induction of either cell cycle arrest or apoptosis (reviewed in Amundsen et al., 1998) . An important mediator of the G1 arrest is the p21/WAF1 protein, a cdk inhibitor which is induced by transcriptional activation by activated p53 (El-Deiry et al., 1993; Petrocelli et al., 1996) . The mechanism by which p53 induces apoptosis is less clear, but may also in some cases involve activation of p53 responsive genes such as bax (Oltvai et al., 1993) . In addition, there are a number of recently identi®ed p53-induced genes (PIGs) which were isolated on the basis of their induction following DNA damage by reactive oxygen species which may also function in p53-dependent apoptosis (Polyak et al., 1997) . The p53 gene is frequently mutated in a wide range of human cancers (Hollstein et al., 1991) . An exception to this general rule appears to be anogenital cancers (Crook et al., 1991; Schener et al., 1991) , the development of which is closely associated with speci®c types of human papillomaviruses (HPVs). HPVs, in common with other DNA tumour viruses such as SV40, adenovirus and EBV, encode proteins able to inhibit p53 growth arrest and apoptotic activities (Lane and Crawford, 1979; Sarnow et al., 1982; Okan et al., 1995) . In the case of high risk oncogenic anogenital HPV types, p53 inactivation is mediated by the viral E6 protein and is brought about by the recruitment of a cellular protein, E6-AP, leading to ubiquitination of p53 and its degradation through the proteasome (Huibregste et al., 1991 Schener et al., 1993 Schener et al., , 1994 Schener et al., , 1995 . In addition to their role in the development of anogenital cancers, HPVs are also closely associated with the development of cutaneous cancers in patients with the rare inherited disease Epidermodysplasia verruciformis (reviewed in Jablonska et al., 1972; Orth, 1987; Majewski and Jablonska, 1995) . These individuals are prone to infection with speci®c types of HPVs and often develop squamous cell carcinomas (SCCs) which frequently harbour HPV types 5 and 8. The cancers in EV individuals predominantly occur at body sites exposed to sunlight, pointing to a role for ultra violet (UV) radiation in the development of the disease (Orth et al., 1979) . In addition to EV, a role for HPVs has also been postulated in the development of non-melanoma skin cancers (NMSC) in both immunocompetent and immunocompromised individuals, such as organ transplant recipients (Jablonska, 1990; Purdie et al., 1993; de Jong-Tieben et al., 1995; Shamanin et al., 1996; Hop¯et al., 1997; Surentheran et al., 1998) . Interestingly, these individuals also often develop NMSC at UV-exposed sites (reviewed in Proby et al., 1996) . Recent epidemiological evidence has indicated that both viral warts and SCCs in transplant recipients contain a broad spectrum of HPV types, many of these being previously uncharacterized. In contrast to anogenital cancers, which are associated with HPV types such as HPV16/18/31/33 and 45 and EVassociated cancers commonly associated with HPV types 5 and 8, a de®nite role for HPVs has not yet been established in the case of NMSC in transplant recipients. UV radiation is known to be an important aetiological agent in the development of skin cancer (see Grossman and Leell, 1997) . Irradiation of the skin causes speci®c types of DNA damage, such as pyrimidine dimers, leading to a strong induction of p53 (Campbell et al., 1993; Hall et al., 1993) which plays an important role in the repair of UV-type damage (Smith et al., 1995) . In marked contrast to anogenital HPVs, the E6 protein of EV HPV types is unable to promote p53 degradation (Steger and P®ster, 1992; Elbel et al., 1997 ), yet their presence in warts and skin carcinomas at UV exposed sites suggests that p53 responses to DNA damaging agents have been overcome.
In this report we have investigated whether early region proteins of skin-associated HPV types, derived from dierent phylogenetic groupings, were able to inhibit apoptosis in response to UV radiation and compared their activity to HPV18. For these experiments we chose three dierent HPV types: the EVassociated HPV5 (group B1); a low risk cutaneous type, HPV10 (group A2); and HPV77, a group A2 type related to HPV10 which was originally identi®ed in both warts and SCCs of a renal transplant recipient (Shamanin et al., 1994; Delius et al., 1998) . The E6 gene from each of the viruses was ampli®ed by PCR and subcloned into the expression vector pcDNA3 and were veri®ed by DNA sequencing. These E6 expression plasmid was then individually transfected into HT1080 cells which contain wild type p53 that can be activated by DNA damaging agents. Transfected cells were selected using G418 to generate polyclonal lines for each of the E6 or vector control Figure 1 (a) UV-induced apoptosis in HT1080 cell lines detected by TUNEL. Individual E6 genes from the various HPV types were ampli®ed by PCR using Pfu polymerase and cloned between the BamHI and EcoRI sites of pcDNA3 (Invitrogen). The expression plasmids were transfected using calcium phosphate/DNA coprecipitation into HT1080 cells which express wild type p53 and transformants grown in DMEM media containing 10% serum supplemented with 500 mg/ml G418. RT/PCR analysis con®rmed the expression of speci®c E6 mRNA in the dierent lines. The cell lines were then irradiated with 25 mJ/cm 2 UVB and then maintained in media containing 10% dialysed serum. After 24 h the cells were ®xed and TUNEL labelled to detect apoptotic nuclei. Brie¯y, the cells were ®xed in 4% paraformaldehyde in PBS for 20 min and then permeabilized by immersion in ice cold methanol for 20 min. Endogenous peroxidase activity was removed by incubating the cells in 1% H 2 O 2 for 20 min and then rinsed three times in PBS. Fragmented DNA ends were labelled with biotin-dUTP using terminal transferase in accordance with the manufacturer's conditions (Pharmacia). Following incubation, the cells were incubated in streptavidin peroxidase (Dako) diluted 1 : 100 in PBS. Colour development was achieved using DAB/H 2 O 2 as substrate in the presence of NiCl 2 before dehydration in graded alcohols and mounting in DePeX (BDH) prior to quantitation. Apoptotic nuclei were readily detected in irradiated cells transfected with empty vector. Very few TUNEL positive cells were detected in cells expressing either HPV5/10 or 18 E6 proteins although a small number were seen in cells expressing HPV77 E6. Black arrowheads denote TUNEL positive apoptotic nuclei displaying features of condensed nuclei and cell fragmentation. (b) Graphical representation of E6 inhibition of apoptosis. HT1080 cells (expressing wild type p53) and E6-derived lines were treated with 25 mJ/cm 2 UVB and the number of apoptotic TUNEL labelled cells counted in ®ve randomly chosen ®elds. The mean number of total or apoptotic cells was determined from the ®ve randomly selected ®elds and the results from three separate experiments averaged. The error bar is the standard deviation of the apoptotic cell number a b Figure 3 (a) p53 protein levels rise in cells expressing cutaneous HPV E6 proteins following UV irradiation. p53 protein levels in E6-expressing cells were investigated 24 h post-UV irradiation as in Figure 1 . For immunohistochemical detection of p53, the cells were ®xed in methanol/acetone (50 : 50 mix) for 10 min and then allowed to air dry. Endogenous peroxidase was removed as above and the cells incubated with the anti-p53 monoclonal antibody DO1. The secondary antibody was a biotin conjugated rabbit antimouse followed by a tertiary layer of strepavidin conjugated HRP. Colour development was as above. (b) Western blot analysis of p53 and p21 levels in HT1080 cells following UV irradiation. The cells were washed 26 with PBS and drained thoroughly. Each 100 mm tissue culture dish was incubated with 200 ml lysis buer (50 mM HEPES, 250 mM NaCl, 0.1% Nonidet-P40 and 16 cocktail protease inhibitors) (Boehringer Mannheim) at 48C for 20 min prior to harvesting. The cellular debris was removed by centrifugation at 13 000 r.p.m. for 2 min and the protein concentration of the supernatant determined using the BioRad Protein Assay reagent. Samples were equalised for protein concentration and were then separated by SDS ± PAGE. The proteins were transferred onto PVDF membrane by Western blotting and the blots probed with speci®c antibodies. The membrane was subsequently developed using the Amersham ECL+Plus kit according to the manufacturer's instructions. The blot was sequentially probed with monoclonal antibodies speci®c for p53 (DO1), p21 (Santa Cruz) and a-Tubulin (Calbiochem) which acted as a loading control a b Figure 2 Cell cycle analysis of HT1080 and E6-expressing lines following UV irradiation. Cells were seeded at 3610 5 in 90 mm dishes and 24 h later exposed to 25 mJ/cm 2 UVB. The cells were subsequently cultured in DMEM containing 10% dialysed FCS and harvested 24 h later. The cells were then ®xed in ethanol and the DNA stained with propidium iodide prior to analysis using a Becton Dickinson FACScan TM analyser using Cell Quest software. The results show that all the E6-expressing cells were resistant to UV-induced apoptosis whilst control cells showed a large increase in the number of cells having fragmented DNA present in the sub-G1 fraction (indicated by the bar) transfected cells. Expression of the relevant E6 genes was con®rmed by RT ± PCR and growth rates of the cells did not dier signi®cantly (data not shown). Each of the transfected cell lines was exposed to a single dose of 25 mJ/cm 2 UVB radiation and after 24 h the cells were examined for characteristic signs of apoptosis, such as blebbing, nuclear condensation and fragmentation (Wyllie, 1980) . As expected, labelling of fragmented nuclear DNA by TUNEL showed no apoptosis in cells transfected with HPV18E6 24 h post UV compared to vector control cells (Figure 1a) . Furthermore, a greatly reduced rate of apoptosis was seen in cells expressing the E6 protein of HPV types 5, 10 and 77 following UV treatment (Figure 1a) . The results of three independent experiments were quantitated and collated (Figure 1b) . In contrast to the eects of the HPV5 and 10 E6 proteins, signi®cant levels of apoptosis were seen in HPV77 E6 transfected cells at this dose of UV. In addition to TUNEL staining to quantitate apoptotic cells, we additionally performed cell cycle analysis on the UV irradiated cells. Each of the HT1080 E6-expressing lines displayed a similar cell cycle pro®le to that of the control unirradiated cells, even after UV treatment (Figure 2 ). In agreement with our TUNEL experiments, only a small fraction of these cells had a sub-G1 DNA content as judged by propoidium iodide staining. In marked contrast, irradiated control cells showed a dramatic increase in the proportion of cells having a sub-G1 DNA content, 28.1% of the irradiated cells versus 3.2% of non-irradiated vector control cells, which was coupled with a reduction in the proportion of cells in the G2/M fraction ( Figure  2 ). To monitor p53 levels following UV induction, the irradiated cells were ®xed and p53 detected by either immunohistochemistry (Figure 3a) or by Western blot (Figure 3b ) using the p53 speci®c monoclonal antibody DO1. Whilst no increase in p53 levels was seen in cells expressing HPV18 E6, p53 levels still increased in cells expressing HPV5, 10 or 77 E6 proteins as was evident by the strong nuclear staining. These results indicate that the E6 proteins of HPV5 and 10 were capable of inhibiting apoptosis in cells that harboured high levels of wild type p53 (Figure 3a) . Furthermore, the UV-induced p53 in the HPV5, 10 and 77 E6 cells appeared to be transcriptionally active since an increase in the p21 protein, a transcriptional target of activated p53, was also observed in these cells (Figure 3b) . These experiments suggest that the E6 protein of cutaneous viruses uncouples the apoptotic and transcriptional activation functions of p53 in a manner which is distinct from the anogenital HPVs. Previous observations indicated that HPV16 and 18 E6 proteins were also able to inhibit p53-independent apoptotic pathways. We therefore extended our investigations on the cutaneous HPV derived E6 proteins to determine whether they also possessed this capability. For this series of experiments we chose the p53-null cell line Saos2. Cell lines expressing the dierent E6 proteins were generated in the same way as for HT1080 cells using G418 selection for transfected cells. The resultant cell lines were irradiated as described above and the number of apoptotic cells was determined 24 h later. In these experiments, performed in triplicate and collated as before (summarized in Figure 4) , each of the E6 proteins investigated was very eective at inhibiting UV-induced apoptosis in the absence of p53. The fact that we observed inhibition of UV-induced apoptosis in each of the cell lines tested indicates that this is a general property which is shared between E6 proteins of phylogenetically diverse groups and that the E6 activity was also independent of the cell type used.
Since the experiments described above had monitored apoptosis in cells exposed to a dose of 25 mJ/ cm 2 UVB and at one time point post irradiation, we were also interested to determine whether the antiapoptotic eect of the dierent cutaneous HPV E6 proteins was transitory compared to HPV18 E6. HT1080 cells were transfected with the dierent E6 constructs plus EGFP and selected using G418 as before. The transfected colonies were irradiated with a single dose of either 15 or 25 mJ/cm 2 UVB and individual colonies were examined by¯uorescent microscopy for apoptosis at 0, 3 and 6 day intervals post UV treatment. Typical results of monitoring randomly chosen individual colonies of similar size over the 6 days are shown in Figure 5 . At the lower UV dose (Figure 5a ) all the E6 proteins inhibited apoptosis very eectively compared to vector control cells, including HPV77 E6. No gross signs of apoptosis were seen even after 6 days suggesting that the eect of E6 was not transitory. Also noteworthy is the fact that the colonies of E6 transfected cells appeared to increase in size over the time course of the experiment and uoresced brighter due to the increased cell numbers, suggesting that the UV treatment had not resulted in a long term growth arrest of these cells. At the higher dose of UV ( Figure 5b ) the HPV18E6 was still very eective at inhibiting apoptosis, whilst the activity of the cutaneous HPV types appeared to be less eective, with the HPV5 E6 protein conferring greatest protection. In agreement with our earlier quantitation of antiapoptotic activity in Figure 1 , the HPV77 E6 protein appeared to be the least eective at inhibiting apoptosis at this UV dose. Figure 4 Inhibition of apoptosis by E6 proteins is independent of p53. The p53 null cell line Saos2 was transfected with each of the E6 expression plasmids to generate E6-expressing cell lines as described in Figure 1 . Cells were irradiated with 25 mJ/cm 2 UVB and the percentage of apoptotic cells determined as described above. All the dierent E6 proteins conferred resistance to UVinduced apoptosis indicating that they all possessed an antiapoptotic activity which functioned in the absence of p53. The results represent the average of three independent experiments. The error bar refers to the standard deviation of the apoptotic cell number
These observations demonstrate that a range of dierent E6 proteins derived from cutaneous HPVs can inhibit apoptosis in either p53 null or wild type cells in response to UV damage. In the case of E6 proteins derived from cutaneous HPV types, this inhibition occurs in the absence of p53 degradation in agreement with previous biochemical studies (Steger and P®ster, 1992; Elbel et al., 1997) . Our results suggest that the ability of E6 proteins to bypass such growth controls is not restricted to high risk anogenital HPV types, but is perhaps a common property shared by E6 proteins. This implies that although all the HPV types investigated targeted apoptotic pathways, the precise mechanisms, especially with respect to p53, employed by the cutaneous viruses was dierent from that of anogenital HPVs. This was highlighted by the fact that even though p53 was induced by UV treatment in each of the cutaneous HT1080 E6-expressing lines and was judged to be transcriptionally active, as seen by the concomitant increase in p21 levels, the cells nevertheless did not undergo apoptosis. The precise mechanism by which these E6 types uncouple p53 transcription and apoptotic functions, possibly by inhibiting the activation of speci®c p53 induced genes more directly involved in apoptosis (Polyak et al., 1997) or by inhibiting other points on the apoptotic cascade, remains to be fully explored.
The fact that all the cutaneous HPV types tested shared a common anti-apoptotic property, even though their primary amino acid sequences dier greatly, has important implications for organ transplant recipients. These patients are exposed to chronic as well as acute UV doses and whose cutaneous lesions, including both warts and cancers, frequently harbour a diverse spectrum of HPV sequences (Shamanin et al., 1994 (Shamanin et al., , 1996 Berkhout et al., 1995; de Jong-Tieben et al., 1995) . Although HPV10 is usually associated with benign proliferations in immunocompetent and immunosuppressed individuals (Favre et al., 1989; Obalek et al., 1992; Shamanin et al., 1994) it has also been found in carcinomas in organ transplant recipients in which the lesions are often multiply infected (Storey et al., 1998) . The fact that the HPV10 E6 protein also inhibited UV-induced apoptosis, suggests that this function may facilitate HPV proliferation. With respect to the anti-apoptotic activity of E6 and the development of HPV-associated NMSC, either other transforming or mutagenic properties of E6 or other virally Figure 5 encoded proteins may also be required during tumour development. In EV or organ transplant patients where HPV-associated tumours predominantly arise at sunexposed sites, an anti-apoptotic E6 activity may serve to aid the survival of HPV-infected lesions exposed to UV damage and may also induce and facilitate the persistence of UV-induced genetic changes. Figure 5 Eects of UV dose over time on E6 expressing cells. To investigate the sensitivity of E6 cells to dierent doses of UV and whether the eects of the cutaneous E6 proteins was transitory, HT1080 cells were transfected with the dierent E6 expression plasmids plus a plasmid expressing EGFP and selected with G418 as before. Cells expressing EGFP¯uoresced brightly under UV illumination enabling individual colonies to be easily monitored over a 6 day time course. When individual EGFP expressing colonies appeared they were irradiated with one of two doses of UVB, either 15 or 25 mJ/cm 2 . Representative individual colonies were selected and then monitored over 6 days for signs of apoptosis under a UV microscope. (A) Shows representative colonies irradiated with 15 mJ/cm 2 and (B) at 25 mJ/cm 2 . At the lower UV dose all the E6 proteins conferred resistance to UV-induced apoptosis as indicated by the near destruction of the vector control cells. The E6 activity was not transitory over the time course of the experiment. At the higher UV dose, none of the cutaneous E6 proteins were able to inhibit apoptosis as eectively as HPV18 E6, HPV5 E6 appearing to confer the greatest resistance
